Chen Ru, Pan Sheng, Lai Keith, Lai Lisa A, Crispin David A, Bronner Mary P, Brentnall Teresa A
Ru Chen, Sheng Pan, Lisa A Lai, David A Crispin, Teresa A Brentnall, Department of Medicine, University of Washington, Seattle, WA 98195, United States.
World J Gastroenterol. 2014 Dec 7;20(45):17037-48. doi: 10.3748/wjg.v20.i45.17037.
To characterize tumor necrosis factor receptor-associated protein 1 (TRAP1) expression in the progression of ulcerative colitis (UC)-associated colorectal cancer.
Chronic UC is an inflammatory bowel disease that predisposes to colorectal cancer. Immunohistochemical analysis was used to evaluate TRAP1 expression on tissue microarrays containing colonic tissues from 42 UC progressors (patients with cancer or dysplasia) and 38 non-progressors (dysplasia/cancer free patients). Statistical analyses of the TRAP1 immunohistochemistry staining were performed using GraphPad Prism. Differences in the TRAP1 level between non-progressors and progressors were tested for statistical significance using the Mann-Whitney test. Receiver operating characteristic curve method was used to quantify marker performance in distinguishing diseased cases from controls.
TRAP1 was up-regulated in the colon tissues from UC progressors, but not in the colon tissues from UC non-progressors. Moreover, up-regulation of TRAP1 preceded the neoplastic changes: it was present in both the dysplastic and non-dysplastic tissues of UC progressors. When TRAP1 staining in rectal tissue was used as a diagnostic marker, it could distinguish progressors from non-progressors with 59% sensitivity and 80% specificity. Our study further showed that the increase of TRAP1 expression positively correlated with the degree of inflammation in the colorectal cancer tissues, which could be related to the increased oxidation present in the colonic mucosa from UC progressors. We then investigated the cellular proteome changes underlying oxidative stress, and found that oxidative stress could induce up-regulation of TRAP1 along with several other negative modulators of apoptosis.
These results suggest that oxidative stress in long standing UC could lead to the increase of cytoprotective protein TRAP1, which in turn could promote cancer progression by preventing or protecting the oxidative damaged epithelial cells from undergoing apoptosis. TRAP1 could be a potential diagnostic marker for UC associated colorectal cancer.
明确肿瘤坏死因子受体相关蛋白1(TRAP1)在溃疡性结肠炎(UC)相关结直肠癌进展过程中的表达特征。
慢性UC是一种易引发结直肠癌的炎症性肠病。采用免疫组织化学分析评估TRAP1在组织微阵列上的表达情况,该组织微阵列包含42例UC进展者(患有癌症或发育异常的患者)和38例非进展者(无发育异常/癌症的患者)的结肠组织。使用GraphPad Prism对TRAP1免疫组织化学染色进行统计分析。采用曼-惠特尼检验检测非进展者和进展者之间TRAP1水平的差异是否具有统计学意义。使用受试者工作特征曲线方法量化标志物在区分患病病例与对照方面的性能。
TRAP1在UC进展者的结肠组织中上调,但在UC非进展者的结肠组织中未上调。此外,TRAP1的上调先于肿瘤性改变:它存在于UC进展者的发育异常和非发育异常组织中。当将直肠组织中的TRAP1染色用作诊断标志物时,它能够以59%的敏感性和80%的特异性区分进展者和非进展者。我们的研究进一步表明,TRAP1表达的增加与结直肠癌组织中的炎症程度呈正相关,这可能与UC进展者结肠黏膜中氧化增加有关。然后我们研究了氧化应激背后的细胞蛋白质组变化,发现氧化应激可诱导TRAP1以及其他几种凋亡负调节因子上调。
这些结果表明,长期UC中的氧化应激可能导致细胞保护蛋白TRAP1增加,这反过来可能通过阻止或保护氧化损伤的上皮细胞凋亡来促进癌症进展。TRAP1可能是UC相关结直肠癌的潜在诊断标志物。